NOVOS Core
The 12-ingredient longevity stack designed by a Harvard / MIT scientific board - one box, one daily protocol, $89/mo.
The longevity stack with a Harvard / MIT scientific board behind it - twelve ingredients in one daily packet, designed to address what the team calls "the 12 hallmarks of aging."
Price: $109/mo · Verified: 2026-07-09 · Editor score: 8.5/10 (how we rank)
The longevity stack with a Harvard / MIT scientific board behind it - twelve ingredients in one daily packet, designed to address what the team calls "the 12 hallmarks of aging."
NOVOS Core is the rare longevity supplement that puts its science up front. The advisory board includes Vera Gorbunova (Rochester), George Church (Harvard), and Pamela Maher (Salk) - names buyers in this category recognize. That doesn't make the product work; it does make it the most credibly-vetted multi-ingredient stack on market.
The formula combines 12 compounds, each tied to a published research line in aging biology: glucosamine sulfate, fisetin, magnesium malate, calcium alpha-ketoglutarate, microalgae L-theanine, hyaluronic acid, microdose lithium, pterostilbene, ginger extract, rhodiola, and others. Pitch: aging is multifactorial. Addressing one pathway with one supplement ignores the other eleven.
Where it wins: scientific board credibility is real. Gorbunova, Church, and Maher in the same advisory roster is unusual. Dosing transparency above category average - every ingredient labeled at milligram, not hidden in proprietary blend. $89/mo replaces ~$200/mo of equivalent single-ingredient stacking from premium brands.
Where it loses: combination products are inherently a compromise. Dose of any single ingredient is necessarily lower than dedicated single-ingredient products. Fisetin included at ~100mg; some senolytic protocols call for 1500mg+. If you've already done lab work and need to address one or two pathways at clinical dosing, NOVOS Core is the wrong shape of solution.
Longevity-pro and founder buyers who want one daily packet covering twelve aging-research-adjacent compounds, value the scientific advisory board credibility, and prefer convenience over single-ingredient optimization.
You have specific lab-identified deficiencies needing higher single-ingredient dosing, you're budget-sensitive at $89/mo, or you prefer dose-flexible single-ingredient stacking.
Pros
- Scientific advisory board with Gorbunova, Church, Maher - elite research credentials
- 12 research-adjacent ingredients in one packet
- Full milligram dosing transparency - no proprietary blends
- $89/mo replaces ~$200/mo of equivalent single-ingredient stacking
- 30-packet box format - operationally simpler than 12 separate bottles
- Subscribe & save ~$10/mo
- Pairs with NOVOS Boost (NMN) for NAD+ pathway coverage
- Manufactured in cGMP facility, third-party tested
- Vegan, non-GMO, gluten-free formulation
Cons
- Per-ingredient doses lower than single-supplement alternatives (fisetin ~100mg vs 1500mg senolytic protocols)
- No head-to-head RCT validating the specific combination at the specific dose vs placebo
- $89/mo is real commitment for buyers without foundational supplements in place
- Some ingredients (microdose lithium) unfamiliar to non-research-adjacent buyers
- Bet-on-the-bundle model means buyers can't adjust individual doses based on labs
Specifications
Most often compared with
Where this fits
NOVOS NOVOS Core cross-shops across several editorial surfaces on this site: the full brand catalog, the buyer-intent tags this item carries and the price band it qualifies for.
NOVOS NOVOS Core - buyer FAQ
What's in NOVOS Core and why 12 ingredients?
Twelve compounds each tied to a distinct published research line in aging biology: glucosamine sulfate, fisetin, magnesium malate, calcium alpha-ketoglutarate, microalgae L-theanine, hyaluronic acid, microdose lithium, pterostilbene, ginger extract, rhodiola, and others. The pitch: aging is multifactorial - addressing one pathway with one supplement leaves the other eleven uncovered. Whether the combination works at these specific doses is the open question.
Is the scientific advisory board legitimate or marketing?
Legitimate. Vera Gorbunova (Rochester), George Church (Harvard), and Pamela Maher (Salk) all have public advisory relationships with NOVOS. (David Sinclair gave early input but is not a NOVOS advisor and runs his own longevity brand, so don't expect his name on the board.) That doesn't guarantee the product works at the doses included, but it does mean researchers with reputational skin in the game vetted the formulation.
NOVOS Core vs taking the 12 ingredients separately?
Separately is more flexible (you can adjust each dose based on labs) and potentially cheaper per-mg, but you're managing 12 bottles, 12 expiration dates, and 12 daily-dose timing decisions. NOVOS Core trades flexibility for compliance - one packet per day, done. For most readers without lab-driven single-ingredient targets, the convenience wins.
Does it actually do anything I can measure?
No head-to-head RCT validates the specific combination at the specific dose vs placebo. The individual ingredients have research; the combination is inferred. Track HRV, sleep architecture, and lab markers (lipids, inflammation, fasting glucose) over 90+ days if you want to verify the effect on your specific biology.
Do I need NOVOS Boost (NMN) too?
Optional. NOVOS Core doesn't include an NAD+ precursor. If you want NAD+ pathway coverage, add NOVOS Boost (~$60/mo additional) or stack any other NMN/NR supplement. Many users skip Boost and use Mitopure (Urolithin A) or a standalone NMN brand instead.